Daniel Landi

Daniel Landi, MD, is a pediatric neuro-oncologist focused on developing and implementing novel immune-based therapies to treat children with brain and spinal cord tumors.  After completing his pediatrics training at Duke University, Dan completed a pediatric hematology/oncology fellowship at Baylor/Texas Children’s in Houston and received additional clinical training in neuro-oncology as a faculty member.  There, as a member of the Center for Cell and Gene Therapy, Dan studied mechanisms for modulating the immune environment to improve the effect of T cell therapies for glioblastoma.  He translated these efforts in clinical trials for children with glioblastoma under the mentorship of Dr. Nabil Ahmed. 

Dr. Landi joined the PRTBTC as a faculty member in 2017 and is currently an assistant professor of neurosurgery and pediatrics.  Dr. Landi’s clinical focus is caring for children with brain and spinal cord tumors as part of a comprehensive team led by Dr. David Ashley, and his research is focused on to developing new therapies as part of the PRTBTC and bringing these discoveries to children.